Pfizer (PFE) Insider Trading & Ownership $24.94 -0.16 (-0.64%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Pfizer (NYSE:PFE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.06%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$107,650.00Number OfInsiders Selling(Last 12 Months)0 Get PFE Insider Trade Alerts Want to know when executives and insiders are buying or selling Pfizer stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PFE Insider Buying and Selling by Quarter Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Pfizer Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/30/2024Scott GottliebDirectorBuy1,000$28.24$28,240.00 10/15/2024Greg LandsmanU.S. Congress Member (D-OH)Sell$29.46$1,001 - $15,0008/9/2024Kathy E. ManningU.S. Congress Member (D-NC)Sell$28.55$1,001 - $15,0008/6/2024C. Scott FranklinU.S. Congress Member (R-FL)Sell$29.30$15,001 - $50,0008/1/2024C. Scott FranklinU.S. Congress Member (R-FL)Sell$30.65$1,001 - $15,0005/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$27.81$15,001 - $50,0003/4/2024Roger WilliamsU.S. Congress Member (R-TX)Sell$25.89$1,001 - $15,0003/1/2024Roger WilliamsU.S. Congress Member (R-TX)Sell$26.58$1,001 - $15,0003/1/2024Roger WilliamsU.S. Congress Member (R-TX)Buy$26.58$1,001 - $15,0002/27/2024Tommy TubervilleU.S. Congress Member (R-AL)Buy$26.89$1,001 - $15,0002/12/2024Earl BlumenauerU.S. Congress Member (D-OR)Buy$27.67$1,001 - $15,00012/28/2023Jared MoskowitzU.S. Congress Member (D-FL)Sell$28.79$1,001 - $15,00012/20/2023John BoozmanU.S. Congress Member (R-AR)Buy$27.63$1,001 - $15,00012/18/2023Shelley Moore CapitoU.S. Congress Member (R-WV)Sell$27.05$1,001 - $15,00012/15/2023Scott GottliebDirectorBuy3,000$26.47$79,410.00 (Data available from 1/1/2013 forward) PFE Insider Trading Activity - Frequently Asked Questions Who is on Pfizer's Insider Roster? The list of insiders at Pfizer includes Alexander R Mackenzie, Douglas M Lankler, Jennifer B Damico, Pfizer Inc, Scott Gottlieb, and William R Carapezzi Jr. Learn more on insiders at PFE. What percentage of Pfizer stock is owned by insiders? 0.06% of Pfizer stock is owned by insiders. Learn more on PFE's insider holdings. Which Pfizer insiders have been buying company stock? The following insiders have purchased PFE shares in the last 24 months: Pfizer Inc ($4,999,999.44), and Scott Gottlieb ($184,650.00). How much insider buying is happening at Pfizer? Insiders have purchased a total of 1,817,594 PFE shares in the last 24 months for a total of $5,184,649.44 bought. Which members of congress are trading Pfizer? Roger Williams (R-TX), Tommy Tuberville (R-AL), Earl Blumenauer (D-OR), and John Boozman (R-AR) have bought shares of Pfizer in the last year totaling $32,000. Greg Landsman (D-OH), Kathy E. Manning (D-NC), C. Scott Franklin (R-FL), Tommy Tuberville (R-AL), Roger Williams (R-TX), Jared Moskowitz (D-FL), Shelley Moore Capito (R-WV), Jerry Moran (R-KS), and Sheldon Whitehouse (D-RI) have sold shares totaling $177,500. Pfizer Key ExecutivesDr. Albert Bourla D.V.M. (Age 62)Ph.D., Chairman of the Board & CEO Compensation: $4.05MMr. David M. Denton (Age 59)Chief Financial Officer & Executive VP Compensation: $1.75MDr. Mikael Dolsten M.D. (Age 66)Ph.D., Chief Scientific Officer and President of Research & Development Compensation: $2.41MMr. Douglas M. Lankler (Age 58)Executive VP & General Counsel Compensation: $1.76MMr. Aamir Malik (Age 48)Executive VP & Chief U.S. Commercial Officer Compensation: $1.89MMs. Jennifer B. Damico (Age 56)Senior VP, Controller & Principal Accounting Officer Ms. Lidia L. Fonseca (Age 55)Executive VP and Chief Digital & Technology Officer Ms. Francesca M. DeMartinoChief Investor Relations OfficerMr. Rady A. Johnson (Age 62)Executive VP and Chief Compliance, Quality & Risk Officer Mr. Andreas J. PanayiotouGlobal Chief Marketing Officer More Insider Trading Tools from MarketBeat Related Companies Johnson & Johnson Insider Selling AbbVie Insider Selling Merck & Co., Inc. Insider Selling Bristol-Myers Squibb Insider Selling Zoetis Insider Selling Royalty Pharma Insider Selling Jazz Pharmaceuticals Insider Selling Corcept Therapeutics Insider Selling Perrigo Insider Selling Supernus Pharmaceuticals Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NYSE:PFE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pfizer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
